Skip to content
Back to meeting Original
M. Elisabeth· @ChildrenNeedUs_ · X·· 2 days agoScore70

divarasib

Body

Next Gen KRAS G12C-mutated inhibitors are already surpassing the first generation cohort.

Divarasib came out of
Genentech/Roche labs.

#ESMO26 #ESMO2026

13 views · 0 likes · 0 reposts · 0 replies

Conference abstracts
引用@
Original Article: Divarasib as Compared with Sotorasib or Adagrasib in 𝘒𝘙𝘈𝘚 G12C–Mutated NSCLC (phase 3 Krascendo 1 trial) https://nej.md/4BiCvbk #ESMO26 | @myESMO
在 X 查看被引用的帖子

Source: M. Elisabeth · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.